|
|
Volumn 12, Issue 8, 2015, Pages 438-
|
|
Skin cancer: T-VEC oncolytic viral therapy shows promise in melanoma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
IPILIMUMAB;
PEMBROLIZUMAB;
TALIMOGENE LAHERPAREPVEC;
ANTINEOPLASTIC AGENT;
IMMUNOLOGICAL ADJUVANT;
ONCOLYTIC VIRUS;
DRUG RESPONSE;
HERPES SIMPLEX VIRUS 1;
HUMAN;
MELANOMA;
METASTATIC MELANOMA;
NOTE;
ONCOLYTIC VIROTHERAPY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
DRUG EFFECTS;
FEMALE;
IMMUNOLOGY;
IMMUNOTHERAPY;
MALE;
PROCEDURES;
SKIN NEOPLASMS;
ADJUVANTS, IMMUNOLOGIC;
ANTINEOPLASTIC AGENTS;
FEMALE;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HERPESVIRUS 1, HUMAN;
HUMANS;
IMMUNOTHERAPY;
MALE;
MELANOMA;
ONCOLYTIC VIROTHERAPY;
ONCOLYTIC VIRUSES;
SKIN NEOPLASMS;
|
|
EID: 84938206749
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc.2015.106 Document Type: Note |
|
Times cited : (34)
|
|
References (1)
|
